Feature

Health sector has spent $464 million on lobbying in 2020


 

The Pharmaceutical Research and Manufacturers of America led the health sector in spending on lobbying through the first three quarters of 2020, and health care as a whole spent more than any of the other 12 sectors of the U.S. economy, according to the Center for Responsive Politics.

Highest-spending lobbyers through third quarter, 2020

PhRMA spent $20.7 million on lobbying through the end of September, good enough for third on the overall list of U.S. companies and organizations. Three other members of the health sector made the top 10: the American Hospital Association ($18.3 million), BlueCross/BlueShield ($16.3 million), and the American Medical Association ($15.2 million), the center reported.

Total spending by the health sector was $464 million from Jan. 1 to Sept. 30, topping the finance/insurance/real estate sector at $403 million, and miscellaneous business at $371 million. Miscellaneous business is the home of the U.S. Chamber of Commerce, the annual leader in such spending for the last 20 years, based on data from the Senate Office of Public Records.

The largest share of health sector spending came from pharmaceuticals/health products, with a total of almost $233 million, just slightly more than the sector’s four other constituents combined: hospitals/nursing homes ($80 million), health services/HMOs ($75 million), health professionals ($67 million), and miscellaneous health ($9.5 million), the center said on OpenSecrets.org.

Taking one step down from the sector level, that $233 million made pharmaceuticals/health products the highest spending of about 100 industries in 2020, nearly doubling the efforts of electronics manufacturing and equipment ($118 million), which came a distant second. Hospitals/nursing homes was eighth on the industry list, the center noted.

Recommended Reading

Twelve end-of-year tax tips: How COVID-19 could lower your tax bite
MDedge Dermatology
Patients can read your clinical notes starting Nov. 2
MDedge Dermatology
Is ‘Med Ed’ changing for better or worse?
MDedge Dermatology
Dermatologists’ role in the development of the skin care industry
MDedge Dermatology
COVID spikes exacerbate health worker shortages in Rocky Mountains, Great Plains
MDedge Dermatology
Chinese American families suffer discrimination related to COVID-19
MDedge Dermatology
HHS extends deadline for patient access to your clinical notes
MDedge Dermatology
Subscription services a consideration for aesthetic patients
MDedge Dermatology
AMA reports a crash in physician revenues, visits over summer
MDedge Dermatology
Frivolous lawsuits: Still a big threat to doctors?
MDedge Dermatology